Jane Street
INDP icon

Jane Street’s Indaptus Therapeutics INDP Stock Holding History

Jane Street’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
+53,811
New +$135K ﹤0.01% 10290
2020
Q3 		– Sell
-18
Closed -$11K – 7507
2020
Q2 		$11K Buy
+18
New +$11.1K ﹤0.01% 6990
2018
Q3 		– Sell
-12
Closed -$120K – 5392
2018
Q2 		$120K Sell
12
-1
-8% -$11.1K ﹤0.01% 4702
2018
Q1 		$185K Buy
+13
New +$184K ﹤0.01% 4484
2015
Q4 		– Sell
-15
Closed -$194K – 4207
2015
Q3 		$194K Buy
+15
New +$197K ﹤0.01% 3203

Other funds holding INDP

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jane Street's INDP Position: Q2 2026 in Review

Jane Street opened a new position in Indaptus Therapeutics (INDP) in Q2 2026: 53,811 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #10290 among its holdings. This is a return to the name: Jane Street previously reported a position in INDP as recently as Q2 2020.

Jane Street first reported a position in INDP in Q3 2015 and has held it in 5 quarters since. The position peaked at $194K in Q3 2015. 9 funds tracked by Wall St. Rank hold INDP as of Q2 2026.

  • Jane Street held 53,811 shares of Indaptus Therapeutics worth $161K as of Q2 2026.
  • Indaptus Therapeutics was a new Jane Street position in Q2 2026.
  • Indaptus Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10290 holding.
  • Jane Street first reported a position in Indaptus Therapeutics in Q3 2015 and has held it in 5 quarters since.
  • Jane Street's Indaptus Therapeutics position peaked at $194K in Q3 2015.
  • 9 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.